Sort
46,585 grants matching “heart failure”
A Novel, Low-Cost, Machine Learning based and Wearable Technology for Monitoring Heart Failure Parameters
$406,221Peshala Thibbotuwawa Gamage · Florida Institute Of Technology · R15 · FY2025 · HL
PRE-VASCULARIZED AND DEGRADABLE PATCHES FOR CORRECTION OF CONGENITAL HEART DEFECTS
$406,219Jeffrey G Jacot · University Of Colorado Denver · R01 · FY2017 · HL
Mechanisms Underlying the Progression of Arterial Stiffness in Hypertension
$406,197Jay D Humphrey · Yale University · R01 · FY2010 · HL
PICOT and Cardiac Hypertrophy
$406,188Roger Joseph Hajjar · Massachusetts General Hospital · R01 · FY2006 · HL
Development Of P2Y Receptor Ligands
$406,169Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Cell type-specific function of LMNA during myocardial stress in the development of cardiomyopathy
$406,144Jason Cheol Choi · Thomas Jefferson University · R01 · FY2020 · HL
Effect of Mitral Regurgitation on Ischemic LV Remodeling
$406,123Robert A Levine · Massachusetts General Hospital · R01 · FY2011 · HL
Genetic Markers of GIK Effect in Acute Coronary Syndrome in the IMMEDIATE Trial
$406,072Inga Peter · Tufts Medical Center · R01 · FY2007 · HL
Molecular Endotypes of ARDS: Identification, Biology, and Differential Response to Therapy
$406,026Carolyn Calfee · University Of California, San Francisco · R01 · FY2016 · HL
Remodeling of the Transverse Tubular System and Ryanodine Receptor Clusters in Dy
$406,022Frank Bernd Sachse · University Of Utah · R01 · FY2011 · HL
Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.
$405,983Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2024 · DA
Translational Pulmonary Vascular Biology Program
$405,948Kurt R Stenmark · University Of Colorado Denver · T32 · FY2015 · HL
Regulation of BAR Function by localized P13K Inhibition
$405,942Howard A Rockman · Duke University · P01 · FY2006 · HL
Ca2+ Regulation in Chronic Hypoxic Pulmonary Hypertention
$405,900James Sk Sham · Johns Hopkins University · R01 · FY2012 · HL
Signal Transduction in the Heart after Cancer Therapy
$405,900Kathleen Louise Gabrielson · Johns Hopkins University · R01 · FY2012 · HL
Regulation and function of cGMP dependent protein kinase in cardiac hypertrophy
$405,900Eiki Takimoto · Johns Hopkins University · R01 · FY2012 · HL
Molecular Mechanisms of Myofilament Dysfunction in Heart Failure
$405,872Pieter P. De Tombe · University Of Illinois At Chicago · P01 · FY2013 · HL
Clinical Core
$405,830Marc A Simon · University Of Pittsburgh At Pittsburgh · P01 · FY2019 · HL
Clinical Core
$405,829Marc A Simon · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · HL
Structure, function, and inhibition of G protein-coupled receptor kinases
$405,826John J G Tesmer · Purdue University · R01 · FY2018 · HL
IGF::OT::IGF HDAC INHIBITORS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION - VITA 2
$405,821Paul Da Silva Jardin · Vascumab, Llc · N01 · FY2017 · HL
Cluster Imaging of Emerging Biomarker Networks in Wound Healing
$405,820Matthias Nahrendorf · Massachusetts General Hospital · R01 · FY2009 · HL
Patient Outcomes 6 and 12 Months After ALTA, OMEGA and EDEN ARDS Network Trials
$405,803Dale Murray Needham · Johns Hopkins University · R01 · FY2009 · HL
MUSCLE POWERED VAD (VENTRICULAR ASSIST DEVICE)--CHRONIC
$405,800Allegheny-Singer Research Institute · R01 · FY2002 · HL
ADULT-DERIVED STEM CELL DIFFERENTIATION IN THE HEART
$405,796Duke University · R01 · FY2005 · HL